InMode Ltd. (INMD)
- Previous Close
18.64 - Open
18.67 - Bid 18.42 x 100
- Ask 18.48 x 400
- Day's Range
18.43 - 18.67 - 52 Week Range
16.72 - 48.25 - Volume
708,921 - Avg. Volume
1,436,323 - Market Cap (intraday)
1.562B - Beta (5Y Monthly) 2.20
- PE Ratio (TTM)
8.75 - EPS (TTM)
2.11 - Earnings Date Jul 25, 2024 - Jul 29, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
25.60
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.
www.inmodemd.comRecent News: INMD
Performance Overview: INMD
Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: INMD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: INMD
Valuation Measures
Market Cap
1.56B
Enterprise Value
797.74M
Trailing P/E
8.75
Forward P/E
9.09
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.41
Price/Book (mrq)
1.92
Enterprise Value/Revenue
1.71
Enterprise Value/EBITDA
4.60
Financial Highlights
Profitability and Income Statement
Profit Margin
38.84%
Return on Assets (ttm)
13.83%
Return on Equity (ttm)
25.54%
Revenue (ttm)
466.26M
Net Income Avi to Common (ttm)
181.11M
Diluted EPS (ttm)
2.11
Balance Sheet and Cash Flow
Total Cash (mrq)
770.54M
Total Debt/Equity (mrq)
0.76%
Levered Free Cash Flow (ttm)
113.63M
Research Analysis: INMD
Company Insights: INMD
INMD does not have Company Insights